D-Wave Qubits 2025 - Quantum AI Project Driving Drug Discovery, Dr. Tateno, Japan Tobacco

This webinar presentation from Dr. Tateno, Chief Science Officer at Japan Tobacco, explores how quantum AI and hybrid quantum-classical computing can accelerate drug discovery and support the development of first-in-class pharmaceutical compounds. The session highlights the use of D-Wave's annealing quantum computing technology to enhance generative AI-driven drug design, improving the speed and quality of molecular discovery while expanding the capabilities of AI-based pharmaceutical research.